GL1X · GenesisL1 explorer

Research workbench

Nanobody targeting human VSIG4 in spacegroup C2

Analyse Nanobody targeting human VSIG4 in spacegroup C2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5IMK
Type
protein
Length
243 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nanobody; V-set and immunoglobulin domain-containing protein 4
UniProt
Q9Y279
Pockets
1 · best druggability 0.37

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BNanobodyprotein12510% helix, 47% strand—
AV-set and immunoglobulin domain-containing protein 4protein1185% helix, 53% strandQ9Y279

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1600.370.7812empty

Interfaces

1 interface between chains.

  • B–A · 801 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 5IMK · Nanobody targeting human Vsig4 in Spacegroup C2 · the same entry in another collection · chain B against B, TM-score 1.00
  • Q9Y279 · AlphaFold monomer V2.0 prediction for V-set and immunoglobulin domain-containing protein… · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.